Acta Gastro-Enterologica Belgica

Aims & Scope

The Journal Acta Gastro-Enterologica Belgica principally publishes peer-reviewed original manuscripts, reviews, letters to editors, book reviews and guidelines in the field of clinical Gastroenterology and Hepatology, including digestive oncology, digestive pathology, as well as nutrition.

Pure animal or in vitro work will not be considered for publication in the Journal.

Translational research papers (including sections of animal or in vitro work) are considered by the Journal if they have a clear relationship to or relevance for clinical hepato-gastroenterology (screening, disease mechanisms and/or new therapies).

Case reports and clinical images will be accepted if they represent an important contribution to the description, the pathogenesis or the treatment of a specific gastroenterology or liver problem.

The language of the Journal is English.

Papers from any country will be considered for publication.

Manuscripts submitted to the Journal should not have been published previously (in English or any other language), nor should they be under consideration for publication elsewhere.

Unsolicited papers are peer-reviewed before it is decided whether they should be accepted, rejected, or returned for revision.

Manuscripts that do not meet the presentation criteria (as indicated below) will be returned to the authors.

Papers that go too far beyond the scope of the journal will be also returned to the authors by the editorial board generally within 2 weeks.

The Journal reserves the right to edit the language of papers accepted for publication for clarity and correctness, and to make formal changes to ensure compliance with AGEB’s style.

Authors have the opportunity to review such changes in the proofs.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.2

SJR (SCImago Journal Rank)

Year	Value
2024	0.486

Quartile

Year	Value
2024	Q3

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Worldwide prevalence, genotype distribution and management of hepatitis C

  Citation: 25

  Authors: P, R, S, F, A, M.-K., A.A., A.G., A, K, G, S, R, R, E

• Belgian consensus guideline on the management of hemorrhoidal disease

  Citation: 25

  Authors: H, G, M.A., P, M, I, P, N, C, P, M, M, D, S, C, D

• Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?

  Citation: 23

  Authors: Q, A, V, J-P, M.P., N

• Portal vein thrombosis: an overview of current treatment options

  Citation: 20

  Authors: A, A

• Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target?

  Citation: 18

  Authors: G, N, G

• The role of neuromodulation in chronic functional constipation : a systematic review

  Citation: 16

  Authors: N, C, S, N, S, J, T, H

• Belgian consensus on irritable bowel syndrome

  Citation: 13

  Authors: S, H, H, J, P, D, A, T, P, T, F, S, H, P, G, M, H, K, T, F, J

• Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension

  Citation: 12

  Authors: S, A, L, H, C, I

• Malnutrition is highly prevalent in hospitalized cirrhotic patients and associates with a poor outcome

  Citation: 12

  Authors: C, F, N, H, G

• Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents

  Citation: 12

  Authors: C, Y, P, G, S, N

---